retatrutide safety clinical trials I've been asked a lot recently about Retatrutide, so I wanted to share some clear, factual information. is not licensed in the UK. It is still in and cannot retatrutide clinical trials safety efficacy

This article outlines the dosing schedule, injection technique, side effects to monitor, and the current regulatory status of retatrutide in the United Kingdom

Gastrointestinal side effects were most common: nausea (43%), diarrhea (33%), constipation (25%), and vomiting (21%) at the 12mg dose

I wrote an article called Ozempic for All, saying on the policy side, we need to be thinking more broadly about how we can make these medications accessible to more of the population

Long-term use over 12-24 week cycles in anecdotal reports from research users in Canada shows consistent improvements in body composition, particularly in the visceral fat compartment